We are live on
!
Find out more
ACM
Argyle Capital Management Portfolio holdings
AUM
$347M
1-Year Est. Return
44.33%
This Fund
S&P 500
This Quarter
Est. Return
+5.2%
1 Year Est. Return
+44.33%
3 Year Est. Return
+95.77%
5 Year Est. Return
+124.66%
10 Year Est. Return
+325.03%
AUM
$309M
AUM Growth
+$12.7M
(+4.3%)
Cap. Flow
-$811K
Cap. Flow
% of AUM
-0.26%
Top 10 Holdings %
Top 10 Hldgs %
23.29%
Holding
133
New
3
Increased
7
Reduced
18
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$273K |
| 2 |
Philip Morris
PM
|
+$211K |
| 3 |
FISV
Fiserv Inc
FISV
|
+$93K |
| 4 |
AT&T
T
|
+$68.3K |
| 5 |
MANT
Mantech International Corp
MANT
|
+$60.5K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRSP
Perspecta Inc. Common Stock
PRSP
|
+$522K |
| 2 |
Merck
MRK
|
+$303K |
| 3 |
SPWR
SunPower Corporation Common Stock
SPWR
|
+$278K |
| 4 |
BlackRock MuniAssets Fund
MUA
|
+$210K |
| 5 |
Altria Group
MO
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 17.64% |
| 3 | Industrials | 15.32% |
| 4 | Financials | 11.88% |
| 5 | Consumer Discretionary | 7.51% |
Similar funds
GCP
AWA
WC
LAM
FFA
VW
1CP
NC
Argyle Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Argyle Capital Management held 133 positions worth $309M, up 4.3% from $297M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Argyle Capital Management's Q2 2021 filing shows 3 new, 7 increased, 18 reduced and 4 closed positions. Its largest new stake was Organon & Co: 8,299 shares worth $251K. The largest sale was Perspecta Inc. Common Stock, an estimated $522K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
- Argyle Capital Management's largest Q2 2021 buy was Organon & Co: 8,299 shares worth $251K.
- Argyle Capital Management added most to Fiserv Inc in Q2 2021, an estimated $93K increase.
- Argyle Capital Management's biggest Q2 2021 reduction was Merck, cutting an estimated $303K.
- Argyle Capital Management fully exited Perspecta Inc. Common Stock in Q2 2021, selling an estimated $522K.
- Argyle Capital Management's ten largest holdings make up 23% of its $309M portfolio in Q2 2021.
- Argyle Capital Management opened 3 new positions and closed 4 in Q2 2021.
- Argyle Capital Management's portfolio value rose 4.3% quarter-over-quarter to $309M.
Based on Argyle Capital Management's 13F filing for Q2 2021, filed 27 Jul 2021.